Trial Details

COMPLETED
Basic Information
Clinical ID c4571
Identifier NCT00306215
Trial Title A Study to Evaluate the Efficacy and Safety of CCX282-B in Subjects With Moderate to Severe Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Crohn's Disease
Interventions DRUG: CCX282-B
Participant Information
Sponsor Amgen
City New South Wales
Country/Region Australia
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2006-03
Primary Completion Date 2008-08
Completion Date 2009-06